Extemporaneous combination therapy with amlodipine/zofenopril in hypertensive patients: a real-world data analysis in Italy

References

• World Health Organization. [accessed 2022 June 1]. Available from: http://www.emro.who.int/media/world-health-day/public-health-problem-factsheet-2013.html.
   Google Scholar
• Tocci G, Nati G, Cricelli C, et al. Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database. J Hum Hypertens. 2017;31(4):258–262.
   PubMed Web of Science ®Google Scholar
• Tocci G, Muiesan ML, Parati G, et al. Trends in prevalence, awareness, treatment, and control of blood pressure recorded From 2004 to 2014 during world hypertension day in Italy. J Clin Hypertens. 2016;18(6):551–556.
   PubMed Web of Science ®Google Scholar
• Levi M, Pasqua A, Cricelli I, et al. Patient adherence to olmesartan/amlodipine combinations: fixed versus extemporaneous combinations. J Manag Care Spec Pharm. 2016;22(3):255–262.
   PubMedGoogle Scholar
• Mennini FS, Marcellusi A, von der Schulenburg JM, et al. Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur J Health Econ. 2015;16(1):65–72.
   PubMed Web of Science ®Google Scholar
• Burnier M, Egan BM. Adherence in hypertension. Circ Res. 2019;124(7):1124–1140.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
   PubMed Web of Science ®Google Scholar
• Murdoch D, Heel RC. Amlodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs. 1991;41(3):478–505.
   PubMed Web of Science ®Google Scholar
• Fares H, DiNicolantonio JJ, O’Keefe JH, et al. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Open Heart. 2016;3(2):e000473.
   PubMed Web of Science ®Google Scholar
• Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004;292(18):2217–2225.
   PubMed Web of Science ®Google Scholar
• Chrysant SG. The ALLHAT study: results and clinical implications. QJM. 2003;96(10):771–773.
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417–2428.
   PubMed Web of Science ®Google Scholar
• Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian cardiac outcomes Trial-Blood pressure lowering arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895–906.
   PubMed Web of Science ®Google Scholar
• Miranda RD, Mion D Jr, Rocha JC, et al. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Clin Ther. 2008;30(9):1618–1628.
   PubMed Web of Science ®Google Scholar
• Fogari R, Mugellini A, Derosa G. Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension. J Renin Angiotensin Aldosterone Syst. 2007;8(3):139–144.
   PubMed Web of Science ®Google Scholar
• Evangelista S, Manzini S. Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril. J Int Med Res. 2005;33(1):42–54.
   PubMed Web of Science ®Google Scholar
• Ambrosioni E. Defining the role of zofenopril in the management of hypertension and ischemic heart disorders. Am J Cardiovasc Drugs. 2007;7(1):17–24.
   PubMed Web of Science ®Google Scholar
• Borghi C, Cicero AF. Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data. Vasc Health Risk Manag. 2006;2(4):341–349.
   PubMedGoogle Scholar
• Guerrero-Garcia C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. DIC. 2018;7:1–9.
   Google Scholar
• Borghi C, Omboni S, Reggiardo G, et al. Efficacy of zofenopril in combination with amlodipine in patients with acute myocardial infarction: a pooled individual patient data analysis of four randomized, double-blind, controlled, prospective studies. Curr Med Res Opin. 2018;34(10):1869–1874.
   PubMed Web of Science ®Google Scholar
• An J, Derington CG, Luong T, et al. Fixed-dose combination medications for treating hypertension: a review of effectiveness, safety, and challenges. Curr Hypertens Rep. 2020;22(11):95.
   PubMed Web of Science ®Google Scholar
• Ravera M, Cannavo R, Noberasco G, et al. High performance of a risk calculator that includes renal function in predicting mortality of hypertensive patients in clinical application. J Hypertens. 2014;32(6):1245–1254.
   PubMed Web of Science ®Google Scholar
• Volpe M, Pegoraro V, Peduto I, et al. Extemporaneous combination therapy with nebivolol/zofenopril in hypertensive patients: usage in Italy. Curr Med Res Opin. 2022;38(10):1673–1681.
   PubMed Web of Science ®Google Scholar
• IQVIA. Osservatorio sull’impatto della pandemia COVID-19 sull’accesso alle cure. Periodo dati: 2019-2020 2021 [cited 2022 Oct 24]. Available from: https://www.farmindustria.it/app/uploads/2021/03/Osservatorio-IQVIA-sullimpatto-pandemia-sullaccesso-alle-cure_Marzo-2021.pdf
   Google Scholar
• Prieto-Merino D, Mulick A, Armstrong C, et al. Estimating proportion of days covered (PDC) using real-world online medicine suppliers’ datasets. J Pharm Policy Pract. 2021;14(1):113.
   PubMed Web of Science ®Google Scholar
• Asamoah-Boaheng M, Osei Bonsu K, Farrell J, et al. Measuring medication adherence in a population-based asthma administrative pharmacy database: a systematic review and meta-analysis. Clin Epidemiol. 2021;13:981–1010.
   PubMed Web of Science ®Google Scholar
• Mancia G, Volpe R, Boros S, et al. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens. 2004;22(1):51–57.
   PubMed Web of Science ®Google Scholar
• Peacock E, Krousel-Wood M. Adherence to antihypertensive therapy. Med Clin North Am. 2017;101(1):229–245.
   PubMed Web of Science ®Google Scholar
• Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598–1605.
   PubMed Web of Science ®Google Scholar
• Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–3035.
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Holt E, Joyce C, et al. Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the cohort study of medication adherence among older adults (CoSMO). J Hypertens. 2015;33(2):412–420.
   PubMed Web of Science ®Google Scholar
• Conn VS, Ruppar TM, Chase JA, et al. Interventions to improve medication adherence in hypertensive patients: systematic review and meta-analysis. Curr Hypertens Rep. 2015;17(12):94.
   PubMed Web of Science ®Google Scholar
• Rea F, Savare L, Franchi M, et al. Adherence to treatment by initial antihypertensive mono and combination therapies. Am J Hypertens. 2021;34(10):1083–1091.
   PubMed Web of Science ®Google Scholar
• Parati G, Kjeldsen S, Coca A, et al. Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis. Hypertension. 2021;77(2):692–705.
   PubMed Web of Science ®Google Scholar
• ESH ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC task force for the management of arterial hypertension. J Hypertens. 2013;31(10):1925–1938.
   PubMed Web of Science ®Google Scholar
• Unger T, Borghi C, Charchar F, et al. 2020 International society of hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982–1004.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;71(19):e127–e248.
   PubMed Web of Science ®Google Scholar
• Hypertension Canada. [accessed 2022 Jun 7]. Available from: https://guidelines.hypertension.ca/chep-resources/
   Google Scholar
• Dusing R, Waeber B, Destro M, et al. Triple-combination therapy in the treatment of hypertension: a review of the evidence. J Hum Hypertens. 2017;31(8):501–510.
   PubMed Web of Science ®Google Scholar
• Effectiveness and safety of combination of amlodipine and zofenopril in hypertensive patients versus each monotherapy (masolino) [cited 2023 Mar 2]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT05279807
   Google Scholar
• Borghi C, Ambrosio G, Van De Borne P, et al. Zofenopril: blood pressure control and cardio-protection. Cardiol J. 2022;29(2):305–318.
   PubMed Web of Science ®Google Scholar